Literature DB >> 31538086

The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas: A Systematic Review.

Hélio A G Teive1,2, Alex T Meira1, Carlos Henrique F Camargo2, Renato P Munhoz3.   

Abstract

BACKGROUND: The frequency and presentation of each of the most common forms of spinocerebellar ataxias (SCAs) varies widely. In the case of the Americas, this diversity is particularly dynamic given additional social, demographic, and cultural characteristics.
OBJECTIVE: To describe the regional prevalence and clinical phenotypes of SCAs throughout the continent.
METHODS: A literature search was performed in both MEDLINE and LILACS databases. The research was broadened to include the screening of reference lists of systematic review articles for additional studies. Investigations dating from the earliest available through 2019. Only studies in English, Portuguese, and Spanish were included. We analyzed publications with genetically confirmed cases only, ranging from robust samples with epidemiological data to case reports and case series from each country or regions.
RESULTS: Overall, SCA3 is the most common form in the continent. Region-specific prevalence and ranking of the common forms vary. On the other hand, region-specific phenotypic variations were not consistently found based on the available literature analyzed, with the exception of the absence of epilepsy in SCA10 consistently described in a particular cluster of cases in South Brazil.
CONCLUSION: Systematic, multinational studies analyzing in detail the true frequencies of SCAs across the Americas as well as distinct clinical signs and clues of each form would be ideal to look for these potential variations.

Entities:  

Keywords:  SCAs; autosomal dominant cerebellar ataxias; hereditary ataxias; spinocerebellar ataxias

Year:  2019        PMID: 31538086      PMCID: PMC6749803          DOI: 10.1002/mdc3.12822

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  71 in total

Review 1.  Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology.

Authors:  G Stevanin; A Dürr; A Brice
Journal:  Eur J Hum Genet       Date:  2000-01       Impact factor: 4.246

2.  [Clinical and genetic studies of a family from Peru affected by spinocerebellar ataxia type 7].

Authors:  M A Castañeda; C Avalos; F R Jerí
Journal:  Rev Neurol       Date:  2000 Nov 16-30       Impact factor: 0.870

3.  Machado-Joseph disease versus hereditary spastic paraplegia: case report.

Authors:  H A Teive; F M Iwamoto; C H Camargo; I Lopes-Cendes; L C Werneck
Journal:  Arq Neuropsiquiatr       Date:  2001-09       Impact factor: 1.420

4.  A survey of spinocerebellar ataxia in South Brazil - 66 new cases with Machado-Joseph disease, SCA7, SCA8, or unidentified disease-causing mutations.

Authors:  L B Jardim; I Silveira; M L Pereira; A Ferro; I Alonso; M do Céu Moreira; P Mendonça; F Ferreirinha; J Sequeiros; R Giugliani
Journal:  J Neurol       Date:  2001-10       Impact factor: 4.849

5.  Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study.

Authors:  C Gaspar; I Lopes-Cendes; S Hayes; J Goto; K Arvidsson; A Dias; I Silveira; P Maciel; P Coutinho; M Lima; Y X Zhou; B W Soong; M Watanabe; P Giunti; G Stevanin; O Riess; H Sasaki; M Hsieh; G A Nicholson; E Brunt; J J Higgins; M Lauritzen; L Tranebjaerg; V Volpini; N Wood; L Ranum; S Tsuji; A Brice; J Sequeiros; G A Rouleau
Journal:  Am J Hum Genet       Date:  2000-12-20       Impact factor: 11.025

6.  Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10.

Authors:  A Rasmussen; T Matsuura; L Ruano; P Yescas; A Ochoa; T Ashizawa; E Alonso
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

7.  Mapping of the gene for a novel spinocerebellar ataxia with pure cerebellar signs and epilepsy.

Authors:  T Matsuura; M Achari; M Khajavi; L L Bachinski; H Y Zoghbi; T Ashizawa
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

8.  Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family.

Authors:  K Gwinn-Hardy; A Singleton; P O'Suilleabhain; M Boss; D Nicholl; A Adam; J Hussey; P Critchley; J Hardy; M Farrer
Journal:  Arch Neurol       Date:  2001-02

9.  A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter.

Authors:  Zoran Brkanac; Laura Bylenok; Magali Fernandez; Mark Matsushita; Hillary Lipe; John Wolff; David Nochlin; Wendy H Raskind; Thomas D Bird
Journal:  Arch Neurol       Date:  2002-08

10.  Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma.

Authors:  Ichiro Yabe; Hidenao Sasaki; Dong-Hui Chen; Wendy H Raskind; Thomas D Bird; Isao Yamashita; Shoji Tsuji; Seiji Kikuchi; Kunio Tashiro
Journal:  Arch Neurol       Date:  2003-12
View more
  5 in total

1.  Reply to Comment on: "The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas: A Systematic Review".

Authors:  Hélio A G Teive; Carlos Henrique F Camargo; Renato P Munhoz
Journal:  Mov Disord Clin Pract       Date:  2020-01-13

2.  Comment on: "The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas: A Systematic Review".

Authors:  Rana Hanna Al-Shaikh; Zbigniew K Wszolek
Journal:  Mov Disord Clin Pract       Date:  2020-01-13

3.  Comment on: The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas.

Authors:  Marlen Guarnaschelli; Malco Rossi; Ana Zajd; Pilar Igarreta
Journal:  Mov Disord Clin Pract       Date:  2020-02-25

4.  Reply to Comment on: The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas.

Authors:  Hélio A G Teive; Carlos Henrique F Camargo; Renato P Munhoz
Journal:  Mov Disord Clin Pract       Date:  2020-02-25

Review 5.  Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.

Authors:  Bart P C van de Warrenburg; Hans van Bokhoven; Marina P Hommersom; Ronald A M Buijsen; Willeke M C van Roon-Mom
Journal:  Stem Cell Rev Rep       Date:  2021-05-25       Impact factor: 5.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.